INVA (STOCKS)
Innoviva, Inc. Common Stock
$23.970000
+0.210000 (+0.88%)
Prev close: $23.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Pavel Raifeld
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,774.07M
- Employees
- 127
- P/E (TTM)
- 7.20
- P/B (TTM)
- 1.51
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
1
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.94 | $0.56 | +1.3790 | +245.81% |
|
Sep 2025 (Q3)
|
$1.08 | $0.49 | +0.5878 | +119.42% |
|
Jun 2025 (Q2)
|
$0.77 | $0.51 | +0.2600 | +50.98% |
|
Mar 2025 (Q1)
|
$-0.74 | $0.30 | -1.0358 | -350.17% |
Financial Statements
| Revenues | $411.33M |
| Benefits Costs and Expenses | $84.47M |
| Cost Of Revenue | $103.66M |
| Costs And Expenses | $84.47M |
| Gross Profit | $307.67M |
| Operating Expenses | $143.92M |
| Selling, General, and Administrative Expenses | $113.32M |
| Research and Development | $30.60M |
| Operating Income/Loss | $163.75M |
| Income/Loss Before Equity Method Investments | $185.43M |
| Income/Loss From Continuing Operations After Tax | $271.17M |
| Income/Loss From Continuing Operations Before Tax | $326.86M |
| Income/Loss From Equity Method Investments | $141.43M |
| Income Tax Expense/Benefit | $55.70M |
| Income Tax Expense/Benefit, Current | $11.85M |
| Income Tax Expense/Benefit, Deferred | $43.85M |
| Interest And Dividend Income, Operating | $21.09M |
| Interest Expense, Operating | $16.70M |
| Net Income/Loss | $271.17M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $271.17M |
| Net Income/Loss Available To Common Stockholders, Basic | $271.17M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $4.02 |
| Diluted Earnings Per Share | $3.30 |
| Basic Average Shares | 67,395,000 |
| Diluted Average Shares | 84,760,000 |
| Assets | $1.64B |
| Current Assets | $727.52M |
| Inventory | $39.17M |
| Other Current Assets | $688.34M |
| Noncurrent Assets | $907.65M |
| Fixed Assets | $1.56M |
| Intangible Assets | $182.16M |
| Other Non-current Assets | $723.94M |
| Liabilities | $462.32M |
| Current Liabilities | $49.70M |
| Accounts Payable | $4.97M |
| Wages | $9.10M |
| Other Current Liabilities | $35.63M |
| Noncurrent Liabilities | $412.63M |
| Equity | $1.17B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.17B |
| Liabilities And Equity | $1.64B |
| Net Cash Flow From Operating Activities | $196.93M |
| Net Cash Flow From Operating Activities, Continuing | $196.93M |
| Net Cash Flow From Investing Activities | $40.50M |
| Net Cash Flow From Investing Activities, Continuing | $40.50M |
| Net Cash Flow From Financing Activities | $8.55M |
| Net Cash Flow From Financing Activities, Continuing | $8.55M |
| Net Cash Flow | $245.98M |
| Net Cash Flow, Continuing | $245.98M |
| Comprehensive Income/Loss | $271.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $271.17M |
| Other Comprehensive Income/Loss | $0.00 |